Parkinson's Disease: Evidence-Based Interventions for Occupational Therapy
Tracking # 20-1037550
Course overview
Occupational therapy professionals have specific skills that can help maximize function and engagement in meaningful activity over the course of Parkinson's disease (PD). This course will describe common clinical presentations of PD. Treatment considerations with a detailed discussion about evidence-based interventions, progressions, and expected outcomes are presented. Examples are used to model best practices for working with patients in the home health and telehealth settings. The goal of this course is to educate occupational therapy professionals about evidence-based interventions for patients with Parkinson's disease.
Subject areas
This course counts toward the state boards and subject areas below.
Alabama State Board of Occupational Therapy
Occupational Therapist
Occupational Therapy Assistant
Arizona Board of Occupational Therapy Examiners
Occupational Therapist
Occupational Therapy Assistant
Florida Board of Occupational Therapy
Occupational Therapist
Occupational Therapy Assistant
Georgia State Board of Occupational Therapy
Occupational Therapist
Occupational Therapy Assistant
Kansas Board of Healing Arts - Occupational Therapy
Occupational Therapist
Occupational Therapy Assistant
Louisiana State Board of Medical Examiners - Occupational Therapy
Occupational Therapist
Occupational Therapy Assistant
MSDOH Bureau of Professional Licensure - Occupational Therapists
Occupational Therapist
Occupational Therapy Assistant
Oklahoma Board of Medical Licensure and Supervision - Occupational Therapy
Occupational Therapist
Occupational Therapy Assistant
South Carolina Board of Occupational Therapy
Occupational Therapist
Occupational Therapy Assistant
Tennessee Board of Occupational Therapy
Occupational Therapist
Occupational Therapy Assistant
Disclosure statements
None of the planners/faculty, unless otherwise noted, for this educational activity have relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.